Schedule 13D ownership disclosure

PHARMACYTE BIOTECH INC

Security class unavailable · CUSIP: 71715X104

Event date: 2019-11-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
95,262,015
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-20-000100
Form type
SC 13D
Filer
Montazeri Nima
CIK
CIK 1811031
Filed
May 06, 2020
Reporting period
Nov 27, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub